“…6 Patients with atypical findings suspected for renal cell carcinoma should undergo a percutaneous renal biopsy, which has a sensitivity and a specificity of 70% -92% and 100%, respectively. 5,6 Although renal lymphoma is often part of a generalized process, our case appears to be limited to the kidney, so-called stage IE diffuse large B-cell lymphoma. This early-stage aggressive lymphoma, may be highly curable with CHOP (cyclophosphamide, doxorubicin, vincristine [Oncovin], and prednisone] plus rituximab, based on the revised International Prognostic Index of Sehn et al, 9 but only 41%-53% of patients with advanced disease are alive and disease free at a median follow-up of 3 years, especially when there is an overexpression of Bcl 2.…”